Stockscreener 앱 받기
3.39
9.84%
-0.37
시간 외 거래:
3.39
전일 마감가:
$3.76
열려 있는:
$3.5
하루 거래량:
3.63M
Relative Volume:
2.74
시가총액:
$689.64M
수익:
-
순이익/손실:
$-283.26M
주가수익비율:
-1.7937
EPS:
-1.89
순현금흐름:
$-273.61M
1주 성능:
-10.32%
1개월 성능:
-19.86%
6개월 성능:
-67.53%
1년 성능:
-3.97%
1일 변동 폭
$2.85
$3.54
1주일 범위
$2.85
$3.94
52주 변동 폭
$2.85
$12.00
사나 바이오테크놀로지 Stock (SANA) Company Profile
명칭
Sana Biotechnology Inc
전화
(206) 701-7914
주소
188 EAST BLAINE STREET, SUITE 400, SEATTLE
사나 바이오테크놀로지 Stock (SANA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-01-16 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-05 | 개시 | Citigroup | Buy |
| 2023-08-14 | 개시 | TD Cowen | Market Perform |
| 2023-05-02 | 개시 | H.C. Wainwright | Neutral |
| 2021-03-01 | 개시 | BofA Securities | Buy |
| 2021-03-01 | 개시 | Goldman | Neutral |
| 2021-03-01 | 개시 | JP Morgan | Neutral |
| 2021-03-01 | 개시 | Morgan Stanley | Overweight |
모두보기
사나 바이오테크놀로지 주식(SANA)의 최신 뉴스
Sana lowered to market perform by JMP over data uncertainty - MSN
Sana Biotechnology (NASDAQ:SANA) Sets New 12-Month Low After Analyst Downgrade - MarketBeat
HC Wainwright Issues Pessimistic Forecast for Sana Biotechnology (NASDAQ:SANA) Stock Price - MarketBeat
Sana Biotechnology stock hits 52-week low at $3.05 - Investing.com
Sana to lay off staff, deepen autoimmune focus in latest retrenchment - BioPharma Dive
Sana Biotechnology (NASDAQ:SANA) Rating Lowered to "Market Perform" at JMP Securities - MarketBeat
Vanguard Group Inc's Strategic Acquisition of Sana Biotechnology Inc Shares - GuruFocus.com
Sana Biotechnology refocuses on autoimmune and diabetes therapies - Investing.com
Sana Biotechnology refocuses on autoimmune and diabetes therapies By Investing.com - Investing.com UK
Sana Biotechnology Announces Increased Focus on Type 1 - GlobeNewswire
Sana Biotechnology (NASDAQ:SANA) Stock Price Down 6.6%Here's Why - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Shares Up 7.7%Still a Buy? - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Stock Price Down 6.4%What's Next? - MarketBeat
Critical Comparison: Sana Biotechnology (NASDAQ:SANA) & SAB Biotherapeutics (NASDAQ:SABS) - Defense World
Is Sana Biotechnology (NASDAQ:SANA) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Why Sana Biotechnology, Inc. (SANA) is the Penny Stock with the Biggest Upside Potential According to Analysts - Insider Monkey
Biotech stock tumbles after unexplained 1,446% gain - MSN
Sana Biotechnology Inc (SANA) looking to reclaim success with recent performance - SETE News
Sana Biotechnology Inc [SANA] Stock sold by Insider Mulligan Richard for $0.61 million - Knox Daily
Market Insights: Sana Biotechnology Inc (SANA)’s Notable Gain of 4.18, Closing at 3.99 - The Dwinnex
Sana Biotechnology Inc (SANA)’s stock price in review: A technical analysis - US Post News
Sana Biotechnology, Inc. (SANA): Jeff Bezos Is Buying This Stock Now - Insider Monkey
Renaissance Technologies LLC Decreases Stock Position in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
SANA’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
SANA Stock Sees Decline of Approximately -8.49% in Last Five Days - Knox Daily
Sana Biotechnology Inc (SANA) can make a big difference with a little luck - SETE News
Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions - Quantisnow
Sana Biotechnology Announces Leadership and CFO Transition - TipRanks
Marshall Wace LLP Has $1.03 Million Stock Holdings in Sana Biotechnology, Inc. (NASDAQ:SANA) - MarketBeat
Sana Biotechnology Inc (SANA)’s Market Momentum: Closing Strong at 4.23, Down -0.47 - The Dwinnex
How did Sana Biotechnology Inc (SANA) fare last session? - US Post News
Sana Biotechnology Inc (SANA) rating initates by Rodman & Renshaw - Knox Daily
SANA Shares Experience Surge in Value - Knox Daily
Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors - Quantisnow
Sana Bio (SANA) Stock Rallies 105% in 3 Months: Here's Why - MSN
A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore - Quantisnow
Sana Biotechnology (NASDAQ:SANA) Stock Price Down 4.2% - MarketBeat
The time has not yet come to remove your chips from the table: Sana Biotechnology Inc (SANA) - SETE News
XTX Topco Ltd Takes Position in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology's SWOT analysis: biotech stock faces pivotal year ahead By Investing.com - Investing.com South Africa
Sana Biotechnology's SWOT analysis: biotech stock faces pivotal year ahead - Investing.com
Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference - GlobeNewswire
Recent Insider Activity Could Benefit Sana Biotechnology Inc (SANA) - Knox Daily
Quarterly Snapshot: Quick and Current Ratios for Sana Biotechnology Inc (SANA) - The Dwinnex
Sana Biotech director Mulligan sells shares worth over $1.19 million - Investing.com
Director Richard Mulligan Sells 300,000 Shares of Sana Biotechno - GuruFocus.com
Sana Biotechnology Inc [SANA] Records 200-Day SMA of $6.71 - Knox Daily
Analysts Provide An Important Insights On Sana Biotechnology Inc (SANA) - Stocks Register
Is Sana Biotechnology Inc (SANA) positioned for future growth? - SETE News
Sana Biotechnology Inc (SANA)’s results reveal risk - US Post News
Massachusetts Financial Services Co. MA Reduces Stock Position in Sana Biotechnology, Inc. (NASDAQ:SANA) - MarketBeat
사나 바이오테크놀로지 (SANA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
사나 바이오테크놀로지 주식 (SANA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Mulligan Richard | Director |
Sep 24 '24 |
Sale |
4.08 |
150,000 |
612,570 |
2,848,121 |
| Mulligan Richard | Director |
Sep 25 '24 |
Sale |
3.89 |
150,000 |
583,170 |
2,698,121 |
2.02%
0.47%
자본화:
|
볼륨(24시간):